Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/3/08 16:31 | 10/30/08 | HMBT | Health | BioPrd | Biological Products, (No Diag | Bollon Arthur | TX | DO | CEO | M.d | 130 | 0.2000 | 0 | 652 | 58 | 1,769 | D | ||||||||||||||
3/16/07 11:13 | 3/14/07 | HMBT | Health | BioPrd | Biological Products, (No Diag | Nino Ghassan | TX | DT | S | -1,170 | 1.17 | 0 | -1,000 | -24 | 3,154 | I | |||||||||||||||
3/21/06 12:09 | 3/17/06 | HMBT | Health | BioPrd | Biological Products, (No Diag | Baron Robert | TX | D | P.m | 9 | 1.79 | 0 | 5 | 19 | 32 | ||||||||||||||||
2/27/06 11:39 | 2/23/06 | HMBT | Health | BioPrd | Biological Products, (No Diag | Baron Robert | TX | D | P | 10 | 1.95 | 0 | 5 | 23 | 27 | ||||||||||||||||
11/23/05 12:13 | 11/21/05 | HMBT | Health | BioPrd | Biological Products, (No Diag | Rosenblum Mark J | TX | O | CFO | P.d | 3 | 1.50 | 0 | 2 | New | 2 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |